Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DIM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100588646C details a scalable route for Aliskiren intermediates, eliminating toxic reagents and column chromatography for cost-effective manufacturing.
Patent CN106316818B reveals metal-free synthesis for dimerization naphthaquinone derivatives ensuring high purity and supply chain stability for global pharmaceutical intermediates.
Patent CN111032650A details a safer, scalable route for EGFR inhibitor intermediates, eliminating hazardous sodium hydride and iron reduction for cost-effective manufacturing.
Advanced patent CN102617607A enables high-purity Cefazolin production with eco-friendly solvents, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN115894184B reveals a novel non-toxic stabilizer synthesis. Achieve cost reduction in specialty chemical manufacturing with high-purity propellant stabilizers.
Patent CN112898156A reveals a novel molecular sieve catalyzed recovery process for 1-(3,3-dimethylcyclohexyl) ethanol, enhancing yield and reducing waste in Musk Eden manufacturing.
Discover a cost-effective, non-cyanide route for high-purity polymethoxy phenylacetic acid. Ideal for API synthesis like CA4 and Pterostilbene precursors.
Advanced sulfonation-methylation route for N,N'-dimethyl cyclohexanediamine. Eliminates hazardous LiAlH4 reduction, ensuring >98% purity and safer industrial scale-up.
Patent CN108948080B reveals a safer triethylsilane-based route for fosaprepitant dimeglumine, offering high purity and scalable manufacturing for global supply chains.
Patent CN102757321B reveals high-purity synthesis route. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Novel NaBH4 reduction method for 5-(3,3-dimethyloxiranyl)-3-methyl-2-penten-1-ol synthesis. Achieves 98% purity with scalable, cost-effective fragrance intermediate production.
Patent CN102161978B reveals a green Rhodococcus strain for Cilastatin intermediates. Achieve high optical purity with reduced environmental impact and lower manufacturing costs.
Patent CN111747859A reveals a solvent-free synthesis route for N-(2,6-xylyl) methyl aminopropionate, offering high yields up to 97% and reduced environmental impact for fungicide manufacturing.
Novel borohydride reduction process yields 95% pure intermediates. Cost-effective scalable synthesis for global pharmaceutical and agrochemical supply chains.
Novel synthetic method for Melonal offers high yield and mild conditions for flavor industry supply chain optimization and cost efficiency.
Patent CN103848757B details high-yield synthesis. Offers supply chain stability and cost efficiency for pharmaceutical manufacturing partners globally.
Patent CN114075137A reveals a high-yield synthesis route for nicosulfuron intermediates, offering significant supply chain stability and cost reduction benefits.
Novel resolution method for cis-chiral intermediate. Reduces cost and improves scalability for pharmaceutical manufacturing supply chains.
Patent CN102337555A reveals a green electrochemical route for 2,4-dimethylanisole using m-xylene and methanol, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN114380748A details a continuous flow synthesis for Pazopanib intermediates, offering enhanced safety, purity, and scalable manufacturing capabilities for global supply chains.